INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 36 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $247,700 | +1.0% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $245,150 | +0.5% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $244,000 | 0.0% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $244,000 | +6.1% | 250,000 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $230,000 | -3.0% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $237,000 | +4.4% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $227,000 | +0.4% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $226,000 | +9.2% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $207,000 | +4.0% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $199,000 | -1.5% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $202,000 | +7.4% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $188,000 | -7.8% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $204,000 | -19.0% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $252,000 | +17.2% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $215,000 | -3.6% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $223,000 | -10.1% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $248,000 | +7.4% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $231,000 | -29.6% | 250,000 | -23.1% | 0.00% | 0.0% |
| Q3 2018 | $328,000 | +14.7% | 325,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $286,000 | +9.2% | 325,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $262,000 | 0.0% | 325,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $262,000 | +12.9% | 325,000 | +8.3% | 0.00% | +100.0% |
| Q3 2017 | $232,000 | -20.5% | 300,000 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $292,000 | +57.0% | 300,000 | +50.0% | 0.00% | +100.0% |
| Q1 2017 | $186,000 | – | 200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 57,420,000 | $44,527,000 | 5.17% |
| Birch Grove Capital LP | 10,003,000 | $7,934,000 | 4.14% |
| PenderFund Capital Management Ltd. | 9,605,000 | $9,491,000 | 2.41% |
| Context Capital Management, LLC | 9,887,000 | $7,671,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $45,738,000 | 0.90% |
| DeepCurrents Investment Group LLC | 35,892,000 | $27,953,000 | 0.74% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 22,977,000 | $18,267,000 | 0.70% |
| WHITEBOX ADVISORS LLC | 23,150,000 | $17,847,000 | 0.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 27,397,000 | $21,720,000 | 0.46% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,435,000 | $15,079,000 | 0.26% |